Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
IVF HARTMANN: half-year revenue and profit rose sharply
IVF HARTMANN increased revenue in the first half of 2026 by 11.3% to CHF 85.9 million. EBIT grew by 27.5% to CHF 12.1 million (margin 14.0%) and net profit rose by 24.7% to CHF 10.3 million, driven by new customers, temporary demand, innovative products, customer-specific services and digital solutions. A revenue increase is still expected for the full year, although growth in the second half is likely to be weaker; the EBIT forecast has been raised to a level above the previous year. The company cites as risks possible margin-pressure effects from falling prices relative to higher-valued inventories and long procurement processes in tactical operational medicine. » More on finanzen.net
Claus Martini steps down as CEO of IVF Hartmann after ten years
Claus Martini has resigned as CEO of IVF Hartmann after ten years at the helm. Further details about the resignation and succession were not given in the brief notice. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 93.06M | - |
| Gross profit | 30.01M | - |
| Net profit | 11.13M | - |
| EBITDA | 15.5M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €325.17M |
Number of shares | 2.38M |
52-week high/low | €163.86 - €131.63 |
Dividend yield | 3.08% |
Dividends TTM | €4.14 |
Beta | 0.21 |
P/E ratio | 14.69 |
PEG ratio | 2.26 |
P/B ratio | 1.90 |
P/S ratio | 1.75 |
Company profile
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses. It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.
| Name | IVF Hartmann |
| CEO | Martin Walther |
| Headquarters | Neuhausen am Rheinfall,
sh Switzerland |
| Website | |
| IPO | 04/14/1995 |
| Employees | 311 |
Ticker symbols
| Exchange | Symbol |
|---|---|
SIX | VBSN.SW |
London Stock Exchange | 0QQM.L |
London | 0QQM.L |